Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells

References

• Beek CH, van Reede EC. The nature and frequency of the histological changes found in psoriasis vulgaris. Arch Dermatol Res. 1977;257(3):255–264.
   PubMed Web of Science ®Google Scholar
• Chamoun A, Goudetsidis L, Poot F, et al. Psoriasis and depression. Rev Med Brux. 2015;36(1):23–28.
   PubMedGoogle Scholar
• Augustin M, Radtke MA. Quality of life in psoriasis patients. Expert Rev Pharmacoecon Outcomes Res. 2014;14(4):559–568.
   PubMed Web of Science ®Google Scholar
• Papoutsaki M, Costanzo A. Treatment of psoriasis and psoriatic arthritis. BioDrugs. 2013;27(1):3–12.
   PubMedGoogle Scholar
• Gorgievska Sukarovska B, Lipozencić J. Topical management of psoriasis – corticosteroids and sparing corticosteroid therapy. Acta Dermatovenerol Croat. 2006;14(3):188–196.
   PubMedGoogle Scholar
• Benáková N. Phototherapy of psoriasis in the era of biologics: still in. Acta Dermatovenerol Croat. 2011;19(3):195–205.
   PubMed Web of Science ®Google Scholar
• Raut AS, Prabhu RH, Patravale VB. Psoriasis clinical implications and treatment: a review. Crit Rev Ther Drug Carrier Syst. 2013;30(3):183–216.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Di Mercurio M, Idolazzi L, et al. Concept of remission in chronic plaque psoriasis. J Rheumatol Suppl. 2015;93:57–60.
   PubMedGoogle Scholar
• Nichols JA, Katiyar SK. Skin photoprotection by natural polyphenols: anti-inflammatory, anti-oxidant and DNA repair mechanisms. Arch Dermatol Res. 2010;302(2):71–83.
   PubMed Web of Science ®Google Scholar
• Sano A. Safety assessment of 4-week oral intake of proanthocyanidin-rich grape seed extract in healthy subjects. Food Chem Toxicol. 2017;108:519–523.
   PubMed Web of Science ®Google Scholar
• Huang LL, Pan C, Wang L, et al. Protective effects of grape seed proanthocyanidins on cardiovascular remodeling in DOCA-salt hypertension rats. J Nutr Biochem. 2015;26(8):841–849.
   PubMed Web of Science ®Google Scholar
• Barnoiu OS, Sequeira-García Del Moral J, Sanchez-Martínez N, et al. American cranberry (proanthocyanidin 120 mg): its value for the prevention of urinary tracts infections after ureteral catheter placement. Actas Urol Esp. 2015;39(2):112–117.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhu Y, Liu Z, et al. Grape seed proanthocyanidin extract ameliorates diabetic bladder dysfunction via the activation of the Nrf2 pathway. PLoS One. 2015;10(5):e0126457.
   PubMed Web of Science ®Google Scholar
• Miao L, Yang SH, Han JX, et al. The protective effect of grape-seed proanthocyanidin extract on oxidative damage induced by zearalenone in kunming mice liver. Int J Mol Sci. 2016;17(6):1, pii: E808.
   Web of Science ®Google Scholar
• Park M K, Park J S, Cho M L, et al. Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(+) regulatory and IL-17(+) pathogenic T cell in autoimmune arthritis. Immunol Lett. 2011;135(1-2):50–58.
   PubMed Web of Science ®Google Scholar
• Hah Y S, Kim J G, Cho H Y, et al. Procyanidins from vitis vinifera seeds induce apoptotic and autophagic cell death via generation of reactive oxygen species in squamous cell carcinoma cells. Oncol Lett. 2017;14(2):1925–1932.
   PubMed Web of Science ®Google Scholar
• Weigle N, McBane S. Psoriasis. Am Fam Physician. 2013;87:626–633.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP. A cutting edge overview: psoriatic disease. Clin Rev Allergy Immunol. 2013;44(2):109–113.
   PubMed Web of Science ®Google Scholar
• Pastore S, Korkina L. Redox imbalance in T cell-mediated skin diseases. Mediators Inflamm. 2010;2010:861949.
   PubMed Web of Science ®Google Scholar
• Emre S, Metin A, Demirseren DD, et al. The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2013;27(3):e370–e375.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Weigert C, Röcken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol. 2007;25(6):574–580.
   PubMed Web of Science ®Google Scholar
• Jadali Z, Eslami MB. T cell immune responses in psoriasis. Iran J Allergy Asthma Immunol August. 2014;13(4):220–222.
   PubMed Web of Science ®Google Scholar
• Lin X, Huang T. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50(6):585–595.
   PubMed Web of Science ®Google Scholar
• Rashmi R, Rao KS, Basavaraj KH. A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol. 2009;34(6):658–663.
   PubMed Web of Science ®Google Scholar
• Yildirim M, Inaloz HS, Baysal V, et al. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol. 2003;17(1):34–36.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med. 2009;47(7):891–905.
   PubMed Web of Science ®Google Scholar
• Nemati H, Khodarahmi R, Sadeghi M, et al. Antioxidant status in patients with psoriasis. Cell Biochem Funct. 2014;32:268–273.
   PubMed Web of Science ®Google Scholar
• Kadam DP, Suryakar AN, Ankush RD, et al. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25:388–392.
   PubMedGoogle Scholar
• Péter I, Jagicza A, Ajtay Z, et al. Psoriasis and oxidative stress. Orv Hetil. 2016;157(45):1781–1785.
   PubMed Web of Science ®Google Scholar
• Bito T, Nishigori C. Impact of reactive oxygen species on keratinocyte signaling pathways. J Dermatol Sci. 2012;68(1):3–8.
   PubMed Web of Science ®Google Scholar
• Said A, Weindl G. Regulation of dendritic cell function in inflammation. J Immunol Res. 2015;2015:1–15.
   Google Scholar
• Wang XY, Chen XY, Li J, et al. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: a case control study. Biomed Pharmacother. 2017;93:1158–1164.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Voyles SV, Armstrong EJ, et al. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 2011;63(1):1–9.
   PubMed Web of Science ®Google Scholar
• Yu XJ, Li CY, Dai HY, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol. 2007;83(3):413–418.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med. 2011;6(6):487–495.
   PubMed Web of Science ®Google Scholar
• Ogawa E, Sato Y, Minagawa A, et al. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2017;10:14139.
   Google Scholar
• Baliwag J, Barnes DH, Johnston A. Cytokines in psoriasis. Cytokine. 2015;73(2):342–350.
   PubMed Web of Science ®Google Scholar
• Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin. 2015;33(1):13–23.
   PubMed Web of Science ®Google Scholar
• Johnson-Huang LM, Lowes MA, Krueger JG. Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis Model Mech. 2012;5(4):423–433.
   PubMed Web of Science ®Google Scholar
• Nicolas JF. Psoriasis: how the epithelium influences the immune response: keratinocytes, dendritic cells and T lymphocytes. Bull Acad Natl Med. 2014;198(1):17–29.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Negrini S, Magnani O, et al. Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis. Expert Opin Drug Saf. 2017;16(10):1173–1179.
   PubMed Web of Science ®Google Scholar
• Malakouti M, Brown GE, Wang E, et al. The role of IL-17 in psoriasis. J Dermatolog Treat. 2015;26(1):41–44.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Cerdeira C, Molares-Vila A, Sánchez-Blanco E, et al. Study on certain biomarkers of inflammation in psoriasis through “OMICS” platforms. Open Biochem J. 2014;8:21–34.
   PubMedGoogle Scholar
• Meyer Zu Horste G, Wu C, Wang C, et al. RBPJ controls development of pathogenic Th17 cells by regulating IL-23 receptor expression. Cell Rep. 2016;16(2):392–404.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li Y, Yang X, et al. Characterization of Th17 and FoxP3(+) treg cells in paediatric psoriasis patients. Scand J Immunol. 2016;83(3):174–180.
   PubMed Web of Science ®Google Scholar
• Chen JG, Lai W, Jiang Y. Expression of Th17/treg cell in patients with psoriasis arthritis and its clinical significance. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012;34(6):617–620.
   PubMedGoogle Scholar
• Kubo R, Muramatsu S, Sagawa Y, et al. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis. J Dermatol Sci. 2017;86(1):46–53.
   PubMed Web of Science ®Google Scholar
• Elloso MM, Gomez-Angelats M, Fourie AM. Targeting the Th17 pathway in psoriasis. J Leukoc Biol. 2012;92(6):1187–1197.
   PubMed Web of Science ®Google Scholar
• Zheng XF, Sun YD, Liu XY. Correlation of expression of STAT3, VEGF and differentiation of Th17 cells in psoriasis vulgaris of Guinea pig. Asian Pac J Trop Med. 2014;7(4):412–420.
   PubMed Web of Science ®Google Scholar
• Hirahara K, Ghoreschi K, Laurence A, et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev. 2010;21(6):425–434.
   PubMed Web of Science ®Google Scholar
• Miyoshi K, Takaishi M, Nakajima K, et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol. 2011;131(1):108–117.
   PubMed Web of Science ®Google Scholar
• Li W, Man XY, Chen JQ, et al. Targeting VEGF/VEGFR in the treatment of psoriasis. Discov Med. 2014;18(98):97–104.
   PubMed Web of Science ®Google Scholar
• Zhang B, Xie S, Su Z, et al. Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling. Sci Rep. 2016;6:S50.
   Web of Science ®Google Scholar
• Gulletta E, Bottoni U, Foti DP. Psoriasis, a new challenge for laboratory medicine. Clin Chem Lab Med. 2013;51(7):1363–1368.
   PubMed Web of Science ®Google Scholar
• Martin DA, Towne JE, Kricorian G, et al. The emerging role of interleukin-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol. 2013;133(1):17–26.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis—part I: clinical and pathologic concepts. J Allergy Clin Immunol. 2011;127(5):1110–1118.
   PubMed Web of Science ®Google Scholar
• Sharma SD, Meeran SM, Katiyar SK. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor- B signaling in in vivo SKH-1 hairless mice. Mol Cancer Ther. 2007;6(3):995–1005.
   PubMed Web of Science ®Google Scholar
• Sun Y, Xiu C, Liu W, et al. Grape seed proanthocyanidin extract protects the retina against early diabetic injury by activating the Nrf2 pathway. Exp Ther Med. 2016;11(4):1253–1258.
   PubMed Web of Science ®Google Scholar
• Chen F, Ye X, Yang Y, et al. Proanthocyanidins from the bark of metasequoia glyptostroboides ameliorate allergic contact dermatitis through directly inhibiting T cells activation and Th1/Th17 responses. Phytomedicine. 2015;22(4):510–515.
   PubMed Web of Science ®Google Scholar
• Chu H, Tang Q, Huang H, et al. Grape-seed proanthocyanidins inhibit the lipopolysaccharide-induced inflammatory mediator expression in RAW264.7 macrophages by suppressing MAPK and NF-κB signal pathways activation. Environ Toxicol Pharmacol. 2016;41:159–166.
   PubMed Web of Science ®Google Scholar
• Roy A M, Baliga M S, Elmets C A, et al. Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways. Neoplasia. 2005;7(1):24–36.
   PubMed Web of Science ®Google Scholar
• García-Pérez ME, Royer M, Duque-Fernandez A, et al. Antioxidant, toxicological and antiproliferative properties of Canadian polyphenolic extracts on normal and psoriatic keratinocytes. J Ethnopharmacol. 2010;132(1):251–258.
   PubMed Web of Science ®Google Scholar
• Lizarraga D, Lozano C, Briedé JJ, et al. The importance of polymerization and galloylation for the antiproliferative properties of procyanidin-rich natural extracts. FEBS J. 2007;274(18):4802–4811.
   PubMed Web of Science ®Google Scholar
• Roy S, Khanna S, Alessio HM, et al. Anti-angiogenic property of edible berries. Free Radic Res. 2002;36(9):1023–1032.
   PubMed Web of Science ®Google Scholar
• Afaq F, Katiyar SK. Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem. 2011;11(14):1200–1215.
   PubMed Web of Science ®Google Scholar
• Nandakumar V, Singh T, Katiyar SK. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett. 2008;269(2):378–387.
   PubMed Web of Science ®Google Scholar
• Li S, Xu M, Niu Q, et al. Efficacy of procyanidins against in vivo cellular oxidative damage: a systematic review and meta-analysis. PLoS One. 2015;10(10):e0139455.
   PubMed Web of Science ®Google Scholar
• Mantena SK, Katiyar SK. Grape seed proanthocyanidins inhibit UV-radiation- induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. Free Radic Biol Med. 2006;40(9):1603–1614.
   PubMed Web of Science ®Google Scholar
• Li KK, Liu CL, Tam JC, et al. In vitro and in vivo mechanistic study of a novel proanthocyanidin, GC-(4→8)-GCG from cocoatea (Camellia ptilophylla) in antiangiogenesis. J Nutr Biochem. 2014;25(3):319–328.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang X, Dai T, et al. Proanthocyanidins, isolated from choerospondias axillaris fruit peels, exhibit potent antioxidant activities in vitro and a novel anti-angiogenic property in vitro and in vivo. J Agric Food Chem. 2016;64(18):3546–3556.
   PubMed Web of Science ®Google Scholar
• Occhipinti A, Germano A, Maffei ME. Prevention of urinary tract infection with oximacro, a cranberry extract with a high content of a-type proanthocyanidins: a pre-clinical double-blind controlled study. Urol J. 2016;13(2):2640–2649.
   PubMed Web of Science ®Google Scholar
• Yang LJ, Zhu DN, Dang YL, et al. Treatment of condyloma acuminata in pregnant women with cryotherapy combined with proanthocyanidins: outcome and safety. Exp Ther Med. 2016;11(6):2391–2394.
   PubMed Web of Science ®Google Scholar
• Mittal A, Elmets CA, Katiyar SK. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis. 2003;24(8):1379–1388.
   PubMed Web of Science ®Google Scholar
• Afshar K, Stothers L, Scott H, et al. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol. 2012;188(4):1584–1587.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Raychaudhuri SK. Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases. Indian J Dermatol. 2009;54(2):100–109.
   PubMedGoogle Scholar
• Murdaca G, Spanò F, Contatore M, et al. Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy. Expert Opin Drug Metab Toxicol. 2014;10(12):1703–1710.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Gulli R, Spanò F, et al. TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis. J Invest Dermatol. 2014;134(10):2503–2509.
   PubMed Web of Science ®Google Scholar
• Fragoulis GE, Siebert S, McInnes IB. Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases. Annu Rev Med. 2016;67:337–353.
   PubMed Web of Science ®Google Scholar
• Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645–653.
   PubMed Web of Science ®Google Scholar
• Conrad C, Gilliet M. Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol. 2018;54(1):102–113.
   PubMed Web of Science ®Google Scholar